Guangdi Wang, Ph.D.
Professor of Chemistry

Telephone Number: 504-520-5076
Room Number: NCF Annex - Room 339
Email Address:



General Chemistry Lab I (Chem1011L)
General Chemistry Lab II (Chem1021 L)
Quantitative Analysis lecture (Chem3210)
Quantitative Analysis lab (Chem3210L)
Instrumental Analysis (Chem4240 w/L)


Short Professional Biography

Dr. Guangdi Wang is Professor of Chemistry and the co-principal investigator and program director of RCMI at Xavier University of Louisiana. He is a member of the Louisiana Cancer Research Consortium where he collaborates with Professors Roy Weiner, Lucio Miele, Bruce Bunnell, Matthew Burow, and other researchers in proteomic studies and therapeutic development for cancer treatment.  He has also maintained active collaborations with researchers from several RCMI institutions including Clark-Atlanta, Morehouse, FAMU, Jackson State, and Universidad Central del Caribe, School of Medicine in Puerto Rico. Dr. Wang has published over 70 scientific papers and 6 patents in the past 20 years.


Research Interest

Dr. Guangdi Wang’s current research focuses on the design, synthesis, and biological evaluation of selective estrogen receptor modulators (SERMs), selective estrogen receptor downregulators (SERDs), HDAC inhibitors, and anti-metastasis and vascular disrupting agents for treatment of cancer.


Current Grant Support

2G12MD007595                                             8/1/2009 – 7/31/2019    
Xavier’s RCMI Cancer Research Center                                        
The goals of Xavier’s RCMI program are to enhance university-wide cancer research infrastructure and faculty research competitiveness by establishing core laboratories and supporting pilot projects.
Role: Co-PI and Program Director
Louisiana Clinical and Translational Science Center Pilot Project (LACaTS)
                                                                 1/23/2014 – 12/31/2015           
Boron-based 4-Hydroxytamoxifen and Endoxifen Prodrugs for Treatment of Breast Cancer.
The goal of this pilot project is to conduct preclinical studies of boron-4OHT and boron-endoxifen to determine the in vivo efficacy and pharmacokinetics.


Recent Publications
  1. Zheng S, Liu J, Wu Y, Huang TL, Wang G, Small-Molecule Inhibitors of Wnt Signaling Pathway: Towards Novel Anticancer Therapeutics, Future Med Chem, 2015, in press.
  2. Wang R, Chen C, Zhang X, Chen G, Zhang Q, Zheng S, Wang G, Chen Q, Synthesis and evaluation of 1,7-diheteroarylhepta-1,4,7-trien-3-ones:a new class of curcumin mimics as anticancer agents, Eu J Med Chem, 2015, in press.
  3. Zhao L-M, Ma F-Y, Jin H-S, Zheng S, Zhong Q, Wang G. Design and synthesis of novel hydroxyanthraquinone nitrogen mustard derivatives as potential anticancer agents via a bioisostere approach, Eu J Med Chem, 2015, 102: 303-309.
  4. Bateman ME, Strong AL, Burow ME, Wang G, Boue SM, Bunnell BA, Bone formation: roles of genistein and daidzein, In Daidzein and Genistein: Food Sources, Biological Activity and Health Benefits, 2015,  ISBN: 978-1-63483-194-9.
  5. Liu J, Pham P,  Skripnikova E, Zheng S, Lovings L, Wang Y, Goyal N, Bellow S, Mensah L, Chatters A, Bratton M, Wiese T, Zhao M, Wang G, Foroozesh M. A Ligand-based drug design, discovery of 4-trifluoromethyl-7,8-pyranocoumarin as a selective inhibitor of human cytochrome P450 1A2, J Med Chem, 2015, 58(16):6481-93 Aug 10. [Epub ahead of print] PubMed PMID: 26222195.
  6. Washington C, Maxwell J, Stevenson J, Malone G, Low Jr. EW, Zhang Q, Wang G, McIntyre NR. Mechanistic Studies of the Tyrosinase-Catalyzed Oxidative Cyclocondensation of 2-Aminophenol to 2-Aminophenoxazin-3-one, Archives of Biochemistry and Biophysics, 2015, 577-578:24-34.
  7. Xiong P, Wang R, Zhang X, DeLa Torre E, Leon F, Zhang Q, Zheng S, Wang G, Chen Q. . Design, Synthesis, and Evaluation of Genistein Analogues as Anti-Cancer Agents. Anticancer Agents Med Chem. 2015;15(9):1197-1203. PubMed PMID: 25991428.
  8. Zhang C, Zhong Q, Zhang Q, Zheng S, Miele L, Wang G, Boron-based endoxifen prodrug as an effective hormone therapy for breast cancer, Breast Cancer Res. Treat., 2015, Jul;152(2):283-91. doi: 10.1007/s10549-015-3461-9. Epub 2015 Jun 14. PubMed PMID: 26071758.
  9. Zhong Q, Zhang C, Zhang Q, Zheng S, Miele L, Wang G, Boronic prodrug of 4-hydroxytamoxifen is more efficacious than tamoxifen with enhanced bioavailability independent of CYP2D6 status, BMC Cancer, 2015, 15:625, DOI 10.1186/s12885-015-1621-2.
  10. Li S, Zhao J, Wang G, Zhu Y, Rabito F, Krousel-Wood M, Chen W, Whelton PK. Urinary triclosan concentrations are inversely associated with body mass index and waist circumference in the US general population: experience in NHANES 2003-2010, International Journal of Hygiene and Environmental Health, 2015, Jun;218(4):401-6. doi: 10.1016/j.ijheh.2015.03.004. Epub 2015 Mar 14.
  11. Wang R, Chen C, Zhang X, Zhang C, Zhong Q, Chen G, Zhang Q, Zheng S, Wang G, Chen QH. Structure-Activity Relationship and Pharmacokinetic Studies of 1,5-Diheteroarylpenta-1,4-dien-3-ones: A Class of Promising Curcumin-Based Anticancer Agents. J Med Chem. 2015 Jun 11;58 (11):4713-26. doi: 10.1021/acs.jmedchem.5b00470. Epub 2015 May 22. PubMed PMID: 25961334.
  12. Mottamal M, Zheng S, Huang TL, Wang G. Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents, Molecules, 2015, 20, 3898-3941.
  13. Parajuli KR, Zhang Q, Liu S, Patel NK, Lu H, Zeng SX, Wang G, Zhang C, You Z. Methoxyacetic acid suppresses prostate cancer cell growth by inducing growth arrest and apoptosis. Am J Clin Exp Urol. 2014 Dec 25;2(4):300-12.
  14. Zheng S, Zhong Q, He L, Mottamal M, Sridhar J, Zhang Q, Wang G. Modification and Biological Evaluation of Thiazole Derivatives as Novel Inhibitors of Metastatic Cancer Cell Migration and Invasion, Journal of Medicinal Chemistry, 2014, 14;57(15):6653-67. doi: 10.1021/jm500724x. PMC4136724.
  15. Zheng S, Zhong Q, Mottamal M, McFerrin H, Zhang Q, Wang G. Design, Synthesis, and Biological Evaluation of Novel Pyridine-Bridged Analogs of Combretastatin-A4 as Anti-cancer Agents, Journal of Medicinal Chemistry, 2014, 57(8):3369-81. doi: 10.1021/ jm500002k. Epub 2014 Apr 7. PubMed PMID: 24669888; PMCID: PMC4002123.
  16. Strong AL, Ohlstein J, Shi Z, Jiang Q, Zhang Q, Zheng S, Boue SM, Elliott S, Gimble JM, Burow ME, Wang G, Bunnell BA. Novel daidzein analogs enhance osteogenic activity of BMSCs and ASCs through estrogen dependent and independent mechanisms, Stem Cell Research and Therapy, 2014, in press.
  17. Samaan N, Zhong Q, Fernandez J, Chen G, Hussain AM, Zheng S, Wang G, Chen Q. Design, synthesis, and evaluation of novel heteroaromatic analogs of curcumin as anti-cancer agents, European Journal of Medicinal Chemistry, 2014, 75, 123-131.
  18. Zheng S, Wang G. Advances in developing estrogen receptor-targeting therapeutics for Tamoxifen-resistant breast cancer, in Medicinal chemistry advances: overcoming multidrug resistance in oncology, Future Medicine series, 2014, accepted.
  19. Scarritt ME, Bonvillain RW, Burkett BJ, Glotser, Zhang Q, Wang G, Betancourt AM, Sullivan DE, Bunnell BA, Hypertensive Rat Lungs Retain Hallmarks of Vascular Disease Upon Decellularization but Support the Growth of Mesenchymal Stem Cells, Tissue Engineering Part A, 2014, 20(9-10):1426-43..
  20. Tian Y, Wang L, Gillespie C, Wang G, Guo S. Leptin induces mammary cancer stem cells through STAT3/VEGFR-2/Notch signaling pathways, PLOS One, 2014, in revision.
  21. Stong A, Jiang Q, Zhang Q, Zheng S, Boue S, Elliott S, Burow ME, Bunnell BA, Wang G. Design, synthesis, and osteogenic activity of daidzein analogs on human mesenchymal stem cells, ACS Med Chem Lett, 2014, 5 (2), 143–148, Publication Date (Web): December 10, 2013.
  22. Zhou W, Wang G, Guo S. Regulation of angiogenesis via Notch signaling in breast cancer and cancer stem cells. BBA Review on Cancer, 2013, Dec; 1836(2): 304-20. doi: 10.1016/j.bbcan.2013.10.003. Epub 2013 Oct 30.
  23. Guo S, Yang L, Wang G, Asea AAA. Glutathione peroxidases in stem, cancer, and cancer stem cells. In Peroxidases: Biochemical Characteristics, Functions, and Potential Applications, Bogaert L and Coppens N Eds. ISBN: 978-1-62808-261-6, 2013.
  24. Kode NR, Vanden Eynde JJ, Mayence A, Wang G, Huang TL.  Design and Synthesis of N1, N5-bis [4-(5-Alkyl-1,2,4-oxadiazol-3-yl)phenyl]glutaramides as potential antifungal prodrugs.  Molecules, 2013, 18(9):11250-11263.
  25. Guo S, Zou J, Wang G. Advances in the proteomic discovery of novel therapeutic targets in cancer, Drug Design, Development and Therapy, 2013, 7, 1259–1271.
  26. Jiang Q, Zheng S, Wang G. Development of new therapeutic agents for the treatment of tamoxifen-resistant breast cancer, Future Medicinal Chemistry, 2013, 5(9): 1023-1035.
  27. Tilghman S, Townley I, Zhong Q, Carriere P, Zou J, Llopis S, Preyan LC, Williams CC, Skripnikova E, Zhang Q, Wang G. Proteomic signatures of acquired letrozole resistance in breast cancer: suppressed estrogen signaling and increased cell motility and invasiveness, Molecular and Cellular Proteomics, 2013, 12(9):2440-2455.
  28. Zheng S, Zhong Q, Jiang Q, Mottamal M, Zhang Q, Zhu N, Burow ME, Worthylake RA, Wang G, Discovery of a series of thiazole derivatives as novel inhibitors of metastatic cancer cell migration and invasion, ACS Medicinal Chemistry Letters, 2013, 4, 191-196.
  29. Antoon JW, Lai R, Salvo V, Tang Y, Nitzchke AM, Martin EC, Elliott S, Nam SY, Xiong W, Rhodes LV, Collins-Burow B, David O, Wang G, Beckman BS, Nephew KP, Burow ME, MEK5/Erk5 Signaling Suppresses Estrogen Receptor Expression and Promotes Hormone-Independent Tumorigenesis, Plos One, 2013, 8(8): e69291. doi:10.1371/journal.pone.0069291
  30. Patel A, Townley I, Wang G, Singh M, Efficacy of Aerosolized Celecoxib Encapsulated Nanostructured Lipid Carrier in Non-small Cell Lung Cancer in Combination with Docetaxel, Pharmaceutical Research, 2013, May;30(5):1435-46.
  31. Rider MA, Zou J, Vanlandingham D, Nuckois J, Higgs S, Zhang Q, Lacey M, Kim J, Wang G, Hong YS, Quantitative proteomic analysis of the Anopheles gambiae(Diptera: Culicidae) midgut infected with o'nyong-nyong virus., J Med Entomol, 2013, Sep;50(5):1077-88. PubMed PMID: 24180113
  32. Guo S, Liu M, Wang G, Yang L, Gonzalez-Perez RR, Regulation of Angiogenesis via Notch Signaling in Human Malignancy, in Tumor Angiogenesis Regulators, in Tumor Angiogenesis Regulators.  Gonzalez-Perez R and Rueda BR ed. May 2013, CRC Press. pp. 37-90.
  33. Major D, Zhang Q, Wang G, Wang H. Oil-dispersant mixtures: understanding chemical composition and its relation to human toxicity, Toxicol and Environ Chem, 2012, Epub Sept 24, 2012.
  34. Liu M, Wang G, Gomez-Fernandez CR, Guo S. GREB1 functions as a growth promoter and is modulated by IL6/STAT3 in breast cancer, Plos One, 2012, 7(10):e46410. Epub 2012 Oct 3. PubMed PMID: 23056300.
  35. Jiang Q, Zhong Q, Zhang Q, Zheng S, Wang G, Boron-based 4-hydroxytamoxifen bioisosteres for treatment of de novo tamoxifen resistance in breast cancer, ACS Medicinal Chemistry Letters, 2012, 3 (5), 392–396.
  36. Abbaraju NV, Boutaghou MN, Townley I, Zhang Q, Wang G, Cole RB, Rees BB, Analysis of tissue proteomes of the Gulf killifish, Fundulus grandis Analysis of killifish tissue proteomes by 2D electrophoresis and MALDI-TOF/TOF mass spectrometry, Integrative and Comparative Biology 2012, 52(5): 626-35.
  37. Bonvillain RW, Danchuk S, Sullivan DE, Betancourt AM, Semon JA, Eagle ME, Mayeux JP,  Gregory AN, Wang G, Townley I, Borg Z, Weiss DJ, Bunnell BA,  A non-human primate model of lung regeneration:detergent-mediated decellularization and recellularization with mesenchymal stem cells, Tissue Engineering Part A, 2012, 18(23-24):2437-52.
  38. Rhodes LV, Tilghman SL, Boue SM, Wang S, Khalili H, Muir SE, Bratton MB, Zhang Q, Wang G, Burow ME, Collins-Burow BM, Glyceollins as novel targeted therapeutic for the treatment of metastatic triple-negative breast cancer, Oncology Lett. 2012, 3, 163-171.
  39. Zhou C, Zhong Q, Rhodes L, Townley I, Bratton MR, Zhang Q, Martin E, Elliott S, Collins-Burow BM, Burow ME, Wang G. Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration. Breast Cancer Research, 2012, Mar 14; 14(2): R45.   PMCID:PMC3446379
  40. Guo S, Liu M, Wang G, Torroella-Kouri M, Gonzalez-Perez RR. Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells. BBA Review on Cancer. 2012 Jan 24. 1825(2):207-222. PubMed PMID: 22289780.
  41. Wang G, Ma P, Zhang Q, Lewis J, Lacey M, Furukawa Y, O'Reilly SE, Meaux S, McLachlan J, Zhang S. Endocrine disrupting chemicals in New Orleans surface waters and Mississippi Sound sediments. J Environ Monit. 2012 May 2; 14(5):1353-64. Epub 2012 Mar 22. PubMed Central PMCID: PMC3345074.
  42. Acharya L, Judeh T, Wang G,  Zhu D, Optimal Signaling Pathway Structural Inference from Unordered and Overlapping Gene Sets, Bioinformatics, 2012 Feb 15;28(4):546-556. Epub 2011 Dec 22. PMCID: PMC3278757.


Campus Map        Directory         Contact Us         EMERGENCY PREPAREDNESS    © Xavier University of Louisiana. All rights reserved.
(504) 486-7411
EST 1925